RESMED/IDR UNRESTR (ASX:RMD) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as low as $17.31. RESMED/IDR UNRESTR shares last traded at $17.41, with a volume of 1,418,078 shares traded.
The company has a debt-to-equity ratio of 66.08, a quick ratio of 1.44 and a current ratio of 2.38. The stock has a market cap of $24.96 billion and a PE ratio of 56.36. The stock has a 50-day moving average price of A$17.19.
RESMED/IDR UNRESTR Company Profile (ASX:RMD)
ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
See Also: Bull Market
Receive News & Ratings for RESMED/IDR UNRESTR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RESMED/IDR UNRESTR and related companies with MarketBeat.com's FREE daily email newsletter.